Summary
The CureCN project aims to develop a curative gene therapy against the ultra-rare Crigler-Najjar syndrome (CN). CN is a life-threatening liver disease which affects one in a million individuals at birth. It is caused by the deficiency of a liver-specific enzyme (uridine...
More information & hyperlinks
Web resources: | https://curecn.eu/ |